#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hyperoxaluria Adenoid cystic carcinoma Hereditary spastic paraplegia Becker's muscular dystrophy Hydrocephalus Selective polysaccharide antibody deficiency Prader-Willi syndrome Glycogen storage disease type I Malformation venous Myxofibrosarcoma Pustular psoriasis Dementia Alzheimer's type PIK3CA-activated mutation Palmar-plantar erythrodysaesthesia syndrome Urethral valves More trials…

    Learn about Rare Diseases

    VEXAS syndrome – Trials in Disease Wiskott-Aldrich syndrome – Basic Information Anaplastic thyroid cancer – Basic Information Isodicentric chromosome 15 syndrome – Diagnostics Synovial sarcoma metastatic Gastrointestinal stromal tumour – Trials in Disease Antithrombin III deficiency Mucopolysaccharidosis III – Treatment Acquired haemophilia Metachromatic leukodystrophy – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Thiamine Fluorouracil Sodium Glucocorticoids Daunorubicin Levamlodipine Succinate Gsk3915393 PIROXICAM SAR443820 Oxycodone Hydrochloride Soya Oil, Purified Maridebart Cafraglutide Tianeptine Alirocumab Suvecaltamide Paracetamol Ph. Eur. Flutafuranol (18F) Aliskiren Levothyroxine Bgb-A445 Salbutamol Sulfate Ph. Eur. More therapies…

    Learn about Your Condition

    Strongyloidiasis Pain Hypertonic bladder Infantile apnoea Benign renal neoplasm Angiosarcoma Peripheral ischaemia Anogenital warts Acne Medication overuse headache Complex regional pain syndrome Gestational diabetes Hereditary optic atrophy Cryoglobulinaemia Supraventricular tachycardia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. University Of Debrecen

University Of Debrecen

Mnaunz Zdestngc Kbqii 2dx Dawseasmm 4ybbm Hdayahf

Want to learn more about this study or check if you can participate? Contact us.

  • A study testing TRIV-509 compared to placebo in adults with moderate to severe atopic dermatitis

    Not recruiting

    2 1
    Investigated Drugs:
    • HUMAN IGG1 BISPECIFIC MONOCLONAL ANTIBODY AGAINST KALLIKREIN-5 AND KALLIKREIN-7
    Bulgaria Czechia Hungary Poland

  • Study of ianalumab for adults with primary immune thrombocytopenia or warm-antibody autoimmune hemolytic anemia who previously responded to ianalumab

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Warm autoimmune haemolytic anaemia
    • Immune thrombocytopenia
    Investigated Drugs:
    • Entecavir
    • Ianalumab
    • Danazol
    Belgium Bulgaria Czechia France Germany Hungary +3

  • A study testing trimodulin in hospitalized adult patients with community-acquired pneumonia including COVID-19 pneumonia

    Not recruiting

    3 1
    Investigated Diseases:
    • Pneumonia
    • COVID-19
    Investigated Drugs:
    • Trimodulin (Human Igm, Iga, Igg Solution)
    Austria Belgium France Germany Hungary Latvia +3

  • A Study of Erenumab Compared to Placebo for Children and Teenagers With Chronic Migraine to Test How Well It Works and How Safe It Is

    Not recruiting

    3 1
    Investigated Drugs:
    • Erenumab
    Belgium Germany Hungary Italy Poland

  • Study of Erenumab Compared to Placebo for Children and Adolescents with Episodic Migraine to Reduce Monthly Migraine Days

    Not recruiting

    3 1
    Investigated Drugs:
    • Erenumab
    Belgium Germany Hungary Italy Poland Portugal +1

  • A Study of Camizestrant Compared to Standard Hormone Therapy for Patients with ER-Positive HER2-Negative Early Breast Cancer After Initial Treatment

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Goserelin
    • Triptorelin
    • Leuprorelin Acetate
    Austria Belgium Bulgaria Croatia Czechia Estonia +10

  • A study comparing cagrilintide and semaglutide combination to semaglutide, cagrilintide, and placebo in adults with type 2 diabetes on metformin

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Cagrilintide
    • Dapagliflozin
    • Metformin
    Bulgaria Croatia Czechia Denmark Finland Germany +9

  • A study testing tozorakimab for long-term treatment of chronic obstructive pulmonary disease in former smokers with repeated flare-ups

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Chronic obstructive pulmonary disease
    Investigated Drugs:
    • Tozorakimab
    • Salbutamol
    Belgium Bulgaria Czechia Denmark Finland France +11

  • A study testing brepocitinib compared to placebo for adults with dermatomyositis to see if it works and is safe

    Not recruiting

    3 1
    Investigated Drugs:
    • Brepocitinib Tosilate
    Belgium Bulgaria Czechia Germany Hungary Italy +6

  • Study of Tozorakimab for Patients with Chronic Obstructive Pulmonary Disease Who Have Symptoms and a History of Flare-ups

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Chronic obstructive pulmonary disease
    Investigated Drugs:
    • Tozorakimab
    • Salbutamol Sulfate
    Belgium Bulgaria Czechia Denmark Finland Hungary +5
Previous Page
1 … 22 23 24 25 26 … 52
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!